
A Strategy of Continued Antiplatelet Agents, Vitamin K Antagonists, and Direct Oral Anticoagulants Throughout the Perioperative Period of Total Knee Arthroplasty in Patients Receiving Chronic Antithrombotic Therapy
Author(s) -
Sachiyuki Tsukada,
Kenji Kurosaka,
Masami Nishino,
Tetsuyuki Maeda,
Naoyuki Hirasawa
Publication year - 2019
Publication title -
jb and js open access
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.786
H-Index - 3
ISSN - 2472-7245
DOI - 10.2106/jbjs.oa.18.00057
Subject(s) - medicine , antithrombotic , perioperative , anesthesia , deep vein , thrombosis , surgery , arthroplasty
Although continuing antithrombotic therapy is desirable to prevent perioperative cardiovascular and cerebrovascular diseases, perioperative blood loss remains a concern in patients undergoing total knee arthroplasty. The purpose of this study was to assess the impact of continuing chronic antithrombotic therapy on blood loss and major bleeding events.